You searched for "scleral"
American Academy of Ophthalmology – Updated textbooks Basic and Clinical Science Course 2018-2019
The American Academy of Ophthalmology publish a series of books entitled Basic and Clinical Science Course every year. It’s a highly regarded series and has often been quoted to me as a good reference set of books. Indeed, I invested...What’s new in wet AMD papers?
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...Reflections on deployment to ICU
Being unexpectedly uprooted from ophthalmology to ICU during the coronavirus pandemic was certainly a challenge, not just clinically, but emotionally and personally. However, it is only through adversary that we learn to appreciate what we have, and there are definitely...The increased use of surgical adjuncts in complex cataract surgeries undertaken in the COVID-19 pandemic
The authors explore whether more complicated cataract operations have been performed in the NHS since the start of the coronavirus pandemic. Restrictions in availability of access to elective cataract surgery during the COVID-19 pandemic and subsequent case prioritisation based on...OBITUARY: A short tribute to Mike Sanders, Neuro-ophthalmologist
Mike Sanders was Consultant Neuro-Ophthalmologist at St Thomas’ Hospital and the National Hospital, Queen Square in London, 1969 to 1999. He passed away on 25 July of this year. Over this 30-year period he had huge influence over the evolution...
Licence to save: a UK survey of anti-VEGF use for the eye
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
